Showing results (371-380 of 389) with videos related to
Sort By:
Pageof 39
Journal of Synchrotron Radiation|July 1, 2017
Pump-probe experiments at the TEMPO beamline using the low-α operation mode of Synchrotron SOLEILMathieu G Silly, Tom Ferté, Marie Agnes Tordeux, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|June 23, 2015
Use of Psychopharmacologic Medications in Adolescents With Restrictive Eating Disorders: Analysis of Data From the National Eating Disorder Quality Improvement CollaborativeMaria C Monge, Sara F Forman, Nicole M McKenzie, et al.The Journal of Physical Chemistry. B|January 15, 2026
The CP2K Program Package Made SimpleMarcella Iannuzzi, Jan Wilhelm, Frederick Stein, et al.Neuron|June 30, 2015
Silencing Nociceptor Neurons Reduces Allergic Airway InflammationSébastien Talbot, Raja-Elie E Abdulnour, Patrick R Burkett, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 10, 2014
Predictors of outcome at 1 year in adolescents with DSM-5 restrictive eating disorders: report of the national eating disorders quality improvement collaborativeSara F Forman, Nicole McKenzie, Rebecca Hehn, et al.Advanced Materials (Deerfield Beach, Fla.)|September 30, 2022
Quantum Advantage in a Molecular Spintronic Engine that Harvests Thermal Fluctuation EnergyBhavishya Chowrira, Lalit Kandpal, Mathieu Lamblin, et al.Advanced Materials (Deerfield Beach, Fla.)|March 16, 2017
Probing a Device's Active AtomsMichał Studniarek, Ufuk Halisdemir, Filip Schleicher, et al.Physical Chemistry Chemical Physics : PCCP|June 16, 2026
The Newton-X platform for mixed quantum-classical dynamicsMario Barbatti, Rafael S Mattos, Baptiste Demoulin, et al.Vaccines|February 28, 2023
Incipient Parallel Evolution of SARS-CoV-2 Deltacron Variant in South BrazilFernando Hayashi Sant'Anna, Tiago Finger Andreis, Richard Steiner Salvato, et al.Journal for Immunotherapy of Cancer|July 11, 2022
TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancerDavid B Rosen, Anne Månsson Kvarnhammar, Burkhardt Laufer, et al.Pageof 39